Atomistry » Chlorine » PDB 6zpd-6zyu » 6zv7
Atomistry »
  Chlorine »
    PDB 6zpd-6zyu »
      6zv7 »

Chlorine in PDB 6zv7: Crystal Structure of Thrombin in Complex with COMPOUND42B

Enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND42B

All present enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND42B:
3.4.21.5;

Protein crystallography data

The structure of Crystal Structure of Thrombin in Complex with COMPOUND42B, PDB code: 6zv7 was solved by M.Schafer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 70.47 / 1.94
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 69.660, 71.400, 71.470, 90.00, 99.61, 90.00
R / Rfree (%) 15.2 / 19

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Thrombin in Complex with COMPOUND42B (pdb code 6zv7). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Thrombin in Complex with COMPOUND42B, PDB code: 6zv7:

Chlorine binding site 1 out of 1 in 6zv7

Go back to Chlorine Binding Sites List in 6zv7
Chlorine binding site 1 out of 1 in the Crystal Structure of Thrombin in Complex with COMPOUND42B


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Thrombin in Complex with COMPOUND42B within 5.0Å range:
probe atom residue distance (Å) B Occ
H:Cl302

b:19.4
occ:1.00
CL1 H:QQW302 0.0 19.4 1.0
C15 H:QQW302 1.7 19.7 1.0
C14 H:QQW302 2.7 20.9 1.0
C16 H:QQW302 2.7 19.9 1.0
O H:PHE227 3.3 18.5 1.0
O H:TRP215 3.4 19.7 1.0
N H:PHE227 3.5 19.3 1.0
CA H:GLY226 3.6 20.1 1.0
N H:TRP215 3.6 18.4 1.0
C H:TRP215 3.7 20.6 1.0
CG1 H:VAL213 3.7 17.1 1.0
N H:SER214 3.8 17.0 1.0
C H:GLY226 3.9 19.5 1.0
CZ H:TYR228 3.9 17.2 1.0
C13 H:QQW302 4.0 22.1 1.0
C H:PHE227 4.0 18.7 1.0
C11 H:QQW302 4.0 20.4 1.0
CE1 H:TYR228 4.1 17.1 1.0
CA H:TRP215 4.1 19.8 1.0
OH H:TYR228 4.1 18.6 1.0
CE2 H:TYR228 4.2 16.1 1.0
C H:SER214 4.2 18.3 1.0
CA H:PHE227 4.4 18.6 1.0
CB H:ALA190 4.4 20.6 1.0
CA H:VAL213 4.4 16.8 1.0
N H:GLY216 4.4 21.7 1.0
C12 H:QQW302 4.5 20.4 1.0
C H:VAL213 4.5 16.7 1.0
CD1 H:TYR228 4.5 17.0 1.0
CA H:SER214 4.6 17.4 1.0
CD2 H:TYR228 4.6 16.1 1.0
CB H:VAL213 4.7 16.8 1.0
CG H:TYR228 4.8 16.7 1.0
OD1 H:ASP189 4.8 22.1 1.0
O H:GLY226 4.9 19.2 1.0
O H:SER214 4.9 19.7 1.0
O H:HOH478 4.9 22.4 1.0
N H:TYR228 5.0 18.2 1.0

Reference:

A.Hillisch, K.M.Gericke, S.Allerheiligen, S.Roehrig, M.Schaefer, A.Tersteegen, S.Schulz, P.Lienau, M.Gnoth, V.Puetter, R.C.Hillig, S.Heitmeier. Design, Synthesis, and Pharmacological Characterization of A Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics. J.Med.Chem. V. 63 12574 2020.
ISSN: ISSN 0022-2623
PubMed: 33108181
DOI: 10.1021/ACS.JMEDCHEM.0C01035
Page generated: Mon Jul 29 18:13:02 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy